How Analysts Feel About STERIS plc (STE) After Touching 52-Week High?

June 13, 2018 - By Kurt Siggers

STERIS plc (NYSE:STE) Logo

Investors sentiment increased to 0.33 in Q1 2018. Its up 0.16, from 0.17 in 2017Q4. It improved, as 2 investors sold STERIS plc shares while 1 reduced holdings. 1 funds opened positions while 0 raised stakes. 21,503 shares or 9.44% more from 19,649 shares in 2017Q4 were reported.
Eqis Capital Management reported 0.02% in STERIS plc (NYSE:STE). Fruth Investment Mgmt reported 0.55% in STERIS plc (NYSE:STE). Alphamark Advsrs Ltd Co accumulated 0.01% or 150 shares. Prudential Public Lc holds 0% or 3,800 shares in its portfolio.

The stock of STERIS plc (NYSE:STE) hit a new 52-week high and has $110.64 target or 5.00 % above today’s $105.37 share price. The 6 months bullish chart indicates low risk for the $8.92 billion company. The 1-year high was reported on Jun, 13 by Barchart.com. If the $110.64 price target is reached, the company will be worth $445.80M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock decreased 0.65% or $0.69 during the last trading session, reaching $105.37. About 393,187 shares traded or 8.43% up from the average. STERIS plc (NYSE:STE) has risen 34.02% since June 13, 2017 and is uptrending. It has outperformed by 21.45% the S&P500.

Analysts await STERIS plc (NYSE:STE) to report earnings on August, 14. They expect $0.98 earnings per share, up 15.29 % or $0.13 from last year’s $0.85 per share. STE’s profit will be $82.92 million for 26.88 P/E if the $0.98 EPS becomes a reality. After $1.24 actual earnings per share reported by STERIS plc for the previous quarter, Wall Street now forecasts -20.97 % negative EPS growth.

STERIS plc (NYSE:STE) Ratings Coverage

Among 3 analysts covering STERIS (NYSE:STE), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. STERIS had 3 analyst reports since January 3, 2018 according to SRatingsIntel. Raymond James downgraded the stock to “Market Perform” rating in Wednesday, January 3 report. The stock of STERIS plc (NYSE:STE) earned “Buy” rating by KeyBanc Capital Markets on Thursday, February 8. The stock of STERIS plc (NYSE:STE) earned “Buy” rating by Northcoast on Thursday, February 8.

Another recent and important STERIS plc (NYSE:STE) news was published by Gurufocus.com which published an article titled: “STERIS PLC (STE) Files 10-K for the Fiscal Year Ended on March 31, 2018” on May 30, 2018.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide. The company has market cap of $8.92 billion. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It has a 37.12 P/E ratio. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

STERIS plc (NYSE:STE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: